NCT03950843View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation

PHASE3UnknownINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

September 30, 2021

Study Completion Date

December 31, 2021

Conditions
Atrial Fibrillation
Interventions
DRUG

CKD-825

"* Dosage Form: capsule~* Dosage: 3 types(low/medium/high dose)~* Frequency: QD(once daily) administration"

DRUG

Placebo oral capsule

"Placebo of CKD-825~* Dosage Form: capsule~* Dosage: NA~* Frequency: QD administration"

Trial Locations (1)

Unknown

RECRUITING

Jong-ll, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY